Dermatology Doctors in Novi, MI Accepting Medicare

8 Dermatology doctors found. Showing 1 - 8

Jennifer Ann Swearingen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 44000 W 12 Mile Rd Ste 103, Novi, MI 48377 Phone: 248-946-4787

Jolanta E Malinowski, M.D, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 44000 W 12 Mile Rd, Suite 210, Novi, MI 48377 Phone: 248-347-8294

Dayoung Ko, MD Dermatology Medicare: Medicare Enrolled Practice Location: 46325 W 12 Mile Rd Ste 370, Novi, MI 48377 Phone: 248-482-2107

Alice C. Watson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 44000 W 12 Mile Rd Ste 103, Novi, MI 48377 Phone: 248-946-4787    Fax: 248-716-5956

Dr. Mark Harbeck, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26850 Providence Pkwy Ste 535, Novi, MI 48374 Phone: 248-380-8900    Fax: 248-380-0812

Lisa Ann Barron, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 44000 W 12 Mile Rd Ste 103, Novi, MI 48377 Phone: 249-946-4787    Fax: 248-716-5956

Alexis B Lyons, MD Dermatology Medicare: Medicare Enrolled Practice Location: 25500 Meadowbrook Rd Ste 180, Novi, MI 48375 Phone: 248-940-1927    Fax: 248-940-1928

Stephen W Sturman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 44000 W 12 Mile Rd, Suite 210, Novi, MI 48377 Phone: 248-347-8294

News Archive

Growing use of mechanical circulatory support causes moral distress among clinicians

The growing use of mechanical circulatory support (MCS) may contribute to high levels of moral distress for clinicians who regularly care for critically ill patients receiving the aggressive but life-sustaining therapy, according to a study in American Journal of Critical Care.

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

Impax Laboratories settles FLOMAX litigation, to launch generic tamsulosin hydrochloride product

Impax Laboratories, Inc. today announced that it has reached agreement with Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. to settle pending U.S. litigation with regard to US Patent No. 4,703,063 for FLOMAX® (generic name: tamsulosin hydrochloride) capsules through the entry of a consent judgment confirming the validity and infringement of the patent. FLOMAX® is a treatment for the functional symptoms of benign prostatic hyperplasia.

Social and executive brain functions critical for effective communication

Impairments in social and executive brain functions hinder effective communication, according to research in patients with dementia recently published in eNeuro.

Doctors group seeks to stem excessive testing

The American College of Physicians is putting out guidelines to help doctors better identify when patients should be screened for specific diseases and when they can be spared the cost and the potentially invasive procedures that follow.

Read more Medical News

› Verified 6 days ago